HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS Doubles Down On K-Beauty Following Target's Glow Studio Launch

This article was originally published in The Rose Sheet

Executive Summary

Hand moisturizers have a prominent presence in CVS' newly expanded K-beauty assortment, along with products for body and lips, priced from $3.49 to $19.99. The announced ramp-up follows Target's introduction of a K-beauty collection curated by specialist e-commerce site Glow Recipe.

You may also be interested in...



Auntie Anne’s Essential Pretzel Oils; Elicina Snail Creams; Personal-Care Launches In Brief

Recently announced launches across personal-care categories, and only one of them an April Fools’ gag. News in brief.  

CVS Joins Retailers Cramming Shelves With K-Beauty Favorites

CVS teamed with Peach & Lily founder Alicia Yoon to curate an assortment of offerings from South Korean skin-care brands and Yoon’s own Peach Slices line, rolling out to 2,100 doors nationwide in April. With Target, Ulta and Sephora also building their K-beauty offerings, mainstream players may face growing competition for shelf space as millennials gravitate to the quirky and fun, and away from science-driven anti-aging.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel